| scholarly article | Q13442814 |
| P50 | author | Pietro Di Fazio | Q56556315 |
| P2093 | author name string | Detlef K Bartsch | |
| Sabine Eckhardt | |||
| Annette Wunderlich | |||
| Alexander I Damanakis | |||
| Silvia Roth | |||
| Thaddeus T Wissniowski | |||
| P2860 | cites work | Novel analogs targeting histone deacetylase suppress aggressive thyroid cancer cell growth and induce re-differentiation. | Q52926182 |
| HMGA2 expression analysis in cytological and paraffin-embedded tissue specimens of thyroid tumors by relative quantitative RT-PCR. | Q54375386 | ||
| HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias. | Q54539822 | ||
| A novel loss-of-function deletion in sodium/iodide symporter gene in follicular thyroid adenoma. | Q54633785 | ||
| Global cancer statistics | Q22241238 | ||
| Oncogenes and Cancer | Q22248112 | ||
| Effects of let-7 microRNA on Cell Growth and Differentiation of Papillary Thyroid Cancer | Q24652758 | ||
| Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation | Q24658400 | ||
| High mobility group a proteins as tumor markers | Q26853205 | ||
| MicroRNA signatures in human cancers | Q27860962 | ||
| The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance | Q28209900 | ||
| Micro-RNA profiling in kidney and bladder cancers | Q28247306 | ||
| The novel histone deacetylase inhibitor thailandepsin A inhibits anaplastic thyroid cancer growth | Q33776640 | ||
| Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism | Q33781748 | ||
| Novel approaches in anaplastic thyroid cancer therapy | Q34458018 | ||
| B-RafV600E inhibits sodium iodide symporter expression via regulation of DNA methyltransferase 1 | Q34669305 | ||
| microRNA-339-5p modulates Na+/I- symporter-mediated radioiodide uptake | Q34982847 | ||
| Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer | Q35622067 | ||
| Advances in Na(+)/I(-) symporter (NIS) research in the thyroid and beyond. | Q35736848 | ||
| Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. | Q36877130 | ||
| Inhibition of miR-146b expression increases radioiodine-sensitivity in poorly differential thyroid carcinoma via positively regulating NIS expression | Q38876856 | ||
| Synergy between HDAC and PARP Inhibitors on Proliferation of a Human Anaplastic Thyroid Cancer-Derived Cell Line. | Q38907017 | ||
| Novel heat shock protein 90 inhibitor NVP-AUY922 synergizes with the histone deacetylase inhibitor PXD101 in induction of death of anaplastic thyroid carcinoma cells | Q38941054 | ||
| A phase I study of the histone deacetylase (HDAC) inhibitor entinostat, in combination with sorafenib in patients with advanced solid tumors | Q38942616 | ||
| H19 promotes pancreatic cancer metastasis by derepressing let-7's suppression on its target HMGA2-mediated EMT. | Q38985755 | ||
| Downregulation of HMGA2 by the pan-deacetylase inhibitor panobinostat is dependent on hsa-let-7b expression in liver cancer cell lines. | Q39334102 | ||
| HMGA2 gene expression analysis performed on cytologic smears to distinguish benign from malignant thyroid nodules | Q39685650 | ||
| Let-7 Represses Carcinogenesis and a Stem Cell Phenotype in the Intestine via Regulation of Hmga2. | Q42420606 | ||
| MicroRNA Role in Thyroid Cancer Development | Q42752709 | ||
| Immunohistochemical profile of the sodium/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections. | Q46331695 | ||
| A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration. | Q51419438 | ||
| P433 | issue | 6 | |
| P921 | main subject | microRNA | Q310899 |
| thyroid cancer | Q826522 | ||
| P304 | page(s) | 1213-1220 | |
| P577 | publication date | 2016-03-09 | |
| P1433 | published in | Journal of Cancer Research and Clinical Oncology | Q2081599 |
| P1476 | title | MicroRNAs let7 expression in thyroid cancer: correlation with their deputed targets HMGA2 and SLC5A5. | |
| P478 | volume | 142 |
| Q89976378 | Analysis of Let-7 Family miRNA in Plasma as Potential Predictive Biomarkers of Diagnosis for Papillary Thyroid Cancer |
| Q55020577 | Epigenetic Modifications in Thyroid Cancer Cells Restore NIS and Radio-Iodine Uptake and Promote Cell Death. |
| Q47247387 | Expression of hsa-let-7b-5p, hsa-let-7f-5p, and hsa-miR-222-3p and their putative targets HMGA2 and CDKN1B in typical and atypical carcinoid tumors of the lung. |
| Q54979096 | Individualised Multimodal Treatment Strategies for Anaplastic and Poorly Differentiated Thyroid Cancer. |
| Q90581944 | Let-7f-5p regulates TGFBR1 in glucocorticoid-inhibited osteoblast differentiation and ameliorates glucocorticoid-induced bone loss |
| Q38439427 | Long noncoding RNA HIT000218960 promotes papillary thyroid cancer oncogenesis and tumor progression by upregulating the expression of high mobility group AT-hook 2 (HMGA2) gene |
| Q92996669 | MicroRNAs as Potential Biomarkers for Chemoresistance in Adenocarcinomas of the Esophagogastric Junction |
| Q57119043 | Role of family microRNA in breast cancer |
| Q90293775 | Selumetinib Activity in Thyroid Cancer Cells: Modulation of Sodium Iodide Symporter and Associated miRNAs |
| Q26744496 | The Role of miRNA in Papillary Thyroid Cancer in the Context of miRNA Let-7 Family |
| Q93106373 | The transcribed pseudogene RPSAP52 enhances the oncofetal HMGA2-IGF2BP2-RAS axis through LIN28B-dependent and independent let-7 inhibition |
| Q54940306 | Upregulation of let-7f-5p promotes chemotherapeutic resistance in colorectal cancer by directly repressing several pro-apoptotic proteins. |
Search more.